VX-371
PS-G202
Phase 2 small_molecule completed
Quick answer
VX-371 for Primary Ciliary Dyskinesia is a Phase 2 program (small_molecule) at VERTEX PHARMACEUTICALS INC / MA with 1 ClinicalTrials.gov record(s).
Program details
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Indication
- Primary Ciliary Dyskinesia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed